You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,875,699


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,875,699 protect, and when does it expire?

Patent 8,875,699 protects SYMBICORT and is included in one NDA.

Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-six patent family members in thirty countries.

Summary for Patent: 8,875,699
Title:Inhaler cap strap
Abstract: An inhaler (1) for dispensing doses of medicament from a container under user activation includes a body (7) which includes a mouthpiece (5) through which the medicament is dispensed and a cap (2) which can be place in a position to substantially occlude the mouthpiece (5). The cap (2) is attached to the body (7) by a strap (3) which pivots from the body (7), the cap (2) being arranged to slide on the strap (3) such that the cap (2) must translate away from the mouthpiece (5) prior to the pivoting of the strap (3).
Inventor(s): Bunce; Martin (Marlborough, GB)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:13/750,082
Patent Claim Types:
see list of patent claims
Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,875,699: An In-Depth Analysis

Introduction

United States Patent 8,875,699, titled "Inhaler cap strap," is a patent that addresses a specific innovation in the design of inhaler devices. This article will delve into the details of the patent, including its scope, claims, and the broader patent landscape it operates within.

Overview of the Patent

The patent, filed under the application number US13/750,082, pertains to an inhaler designed for dispensing doses of medicament from a container under user activation. The key components include a body with a mouthpiece and a cap strap that enhances the usability and safety of the inhaler[1].

Key Components and Design

Body and Mouthpiece

The inhaler body includes a mouthpiece through which the user inhales the medicament. This design ensures that the medicament is delivered directly to the user's lungs, enhancing the efficacy of the treatment[1].

Cap Strap

The cap strap is a critical innovation in this patent. It is designed to secure the cap of the inhaler, preventing it from getting lost or misplaced. The strap can be made from elastic or other materials, ensuring flexibility and durability[1].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Independent Claims

  • The patent claims an inhaler with a body, a mouthpiece, and a cap strap. The cap strap is specifically designed to secure the cap to the body, ensuring it remains attached even when not in use[1].

Dependent Claims

  • These claims further detail the materials and methods used in the construction of the inhaler and its components. For example, the use of plastic, elastic materials, and the manufacturing processes involved[1].

Patent Landscape Analysis

Technological Domain

Patent landscape analysis helps in understanding the entire landscape of a technology domain. For inhaler devices, this analysis would reveal trends, market developments, and competitive activities such as mergers and acquisitions, in/out-licensing, and litigation[3].

Legal Status and Expiry Dates

The legal status of the patent (active, pending, lapsed, revoked, or expired) and the expected expiry dates are crucial for decision-making. As of the current date, US8875699B2 is active, but its expiry date would be a key factor in planning future innovations or licensing agreements[3].

Market Developments

The patent landscape study would also highlight market developments such as new product launches, regulatory changes, and technological advancements in the field of inhaler devices. This information is vital for companies looking to innovate or expand their product lines[3].

Competitive Insights

Competitor Analysis

Understanding the patent landscape helps in identifying competitors and their patent portfolios. This analysis can reveal gaps in the market and opportunities for innovation that do not infringe on existing patents[3].

Litigation and Opposition Activities

The patent landscape report would also include details on litigation and opposition activities related to similar patents. This information can help in avoiding potential legal conflicts and in strategizing defense or offense in patent disputes[3].

Implications for Innovators and Patent Practitioners

Claim Construction and Indefiniteness

The construction of claims in the patent is critical. Claims must be clear and definite to avoid indefiniteness issues, which can lead to the patent being invalidated. The Federal Circuit has emphasized that claim construction is a question of law and must be reviewed de novo[2].

Practical Applications

The USPTO guidance update on AI patents, though not directly related to this inhaler patent, highlights the importance of practical applications in patent claims. For medical devices like inhalers, demonstrating how the invention improves technology or provides a practical application is essential for patent eligibility[4].

Real-World Applications and Benefits

User Safety and Convenience

The cap strap innovation in this patent enhances user safety by preventing the cap from getting lost, which could lead to contamination or improper use of the inhaler. This design also adds convenience, as the user does not have to worry about misplacing the cap[1].

Market Impact

The introduction of such an inhaler could impact the market by offering a more user-friendly and safe product. This could lead to increased market share and customer satisfaction, especially among patients who rely on inhalers for chronic conditions.

Key Takeaways

  • Innovative Design: The patent introduces an innovative cap strap design that enhances the usability and safety of inhaler devices.
  • Patent Landscape: Understanding the patent landscape is crucial for identifying market trends, competitors, and potential legal issues.
  • Claim Construction: Clear and definite claim construction is essential to avoid legal challenges.
  • Practical Applications: Demonstrating practical applications and improvements in technology is vital for patent eligibility.
  • Market Impact: The innovation could lead to increased market share and customer satisfaction due to its user-friendly and safe design.

FAQs

What is the main innovation in United States Patent 8,875,699?

The main innovation is the cap strap designed to secure the cap of the inhaler, preventing it from getting lost or misplaced.

How does the cap strap enhance user safety?

The cap strap ensures that the cap remains attached to the inhaler body, preventing contamination and improper use.

What is the significance of patent landscape analysis for this patent?

Patent landscape analysis helps in understanding market trends, identifying competitors, and avoiding potential legal conflicts.

How important is claim construction in patent validity?

Claim construction is critical as it must be clear and definite to avoid indefiniteness issues that could lead to the patent being invalidated.

What are the potential market impacts of this innovation?

The innovation could lead to increased market share and customer satisfaction due to its user-friendly and safe design.

Sources

  1. US8875699B2 - Inhaler cap strap - Google Patents
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC. - CAFC
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,875,699

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astrazeneca SYMBICORT budesonide; formoterol fumarate dihydrate AEROSOL, METERED;INHALATION 021929-001 Jul 21, 2006 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Astrazeneca SYMBICORT budesonide; formoterol fumarate dihydrate AEROSOL, METERED;INHALATION 021929-002 Jul 21, 2006 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,875,699

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden0303029-3Nov 17, 2003

International Family Members for US Patent 8,875,699

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 047124 ⤷  Subscribe
Austria 369167 ⤷  Subscribe
Australia 2004289156 ⤷  Subscribe
Brazil PI0416636 ⤷  Subscribe
Canada 2545445 ⤷  Subscribe
China 100493643 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.